Ultragenyx Pharmaceutical (RARE)
(Real Time Quote from BATS)
$28.90 USD
+0.19 (0.66%)
Updated Sep 18, 2025 11:04 AM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
RARE 28.90 +0.19(0.66%)
Will RARE be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RARE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RARE
IONS Up on FDA's Breakthrough Tag for ION582 in Angelman Syndrome
RARE Reports Positive Long-Term Data From Metabolic Disorder Study
RARE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y
Ultragenyx (RARE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Earnings Preview: Verastem (VSTM) Q2 Earnings Expected to Decline
Other News for RARE
RARE forms 50 Day Moving Average Resistance on September 17
Pocket Pivot appears for RARE after 1.66% move
20 Day Moving Average Resistance appears for RARE after 4.32% move
Tracking Baker Brothers Portfolio - Q2 2025 Update
Is RARE ready to move lower? Fell Below 20 Day Moving Average shows up after dropping 2.95%